P153 LIGELIZUMAB REDUCES RESCUE MEDICATION USE IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: PHASE 2B STUDY RESULTS

Autor: Sitz, K., Soong, W., Lanier, B., Kobayashi, K., Barve, A., Hua, E., Janocha, R., Severin, T.
Zdroj: In Annals of Allergy, Asthma & Immunology November 2019 123(5) Supplement:S28-S28
Databáze: ScienceDirect